BDX Insider Trading
BECTON DICKINSON & CO | Surgical & Medical Instruments & Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at BECTON DICKINSON & CO provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2022-02-07 18:42 | 2022-02-03 | Conroy Alexandre | Officer - EVP of Integrated Supply Chain | OPT+S | $270.16 | 6,410 | $1,731,726 | 21,260 | 0.0% |
| 2021-12-17 17:41 | 2021-12-16 | Larson Betty D | Officer - EVP HR & CHRO | OPT+S | $255.00 | 3,341 | $851,955 | 5,872 | 0.0% |
| 2021-12-09 16:09 | 2021-12-07 | Spoerel Thomas J | Officer - VP Controller & Chief Acct Off | SELL | $250.00 | 233 | $58,250 | 1,079 | -17.8% |
| 2021-09-09 00:52 | 2021-09-08 | Spoerel Thomas J | Officer - VP Controller & Chief Acct Off | SELL | $260.00 | 267 | $69,420 | 1,018 | -20.8% |
| 2021-09-09 00:40 | 2021-09-08 | Hickey David | Officer - EVP & President, Life Sciences | SELL | $260.00 | 500 | $130,000 | 3,586 | -12.2% |
| 2021-09-08 17:47 | 2021-09-08 | RIMEL REBECCA W | Director | SELL | $260.00 | 500 | $130,000 | 10,618 | -4.5% |
| 2021-09-07 16:46 | 2021-09-03 | Lim James C | Officer - Executive Vice President | OPT+S | $257.44 | 6,956 | $1,790,753 | 19,768 | 0.0% |
| 2021-09-03 17:01 | 2021-09-03 | RIMEL REBECCA W | Director | SELL | $257.10 | 500 | $128,550 | 11,118 | -4.3% |
| 2021-09-03 15:36 | 2021-09-02 | RIMEL REBECCA W | Director | SELL | $254.00 | 244 | $61,976 | 11,618 | -2.1% |
| 2021-08-31 15:54 | 2021-08-30 | RIMEL REBECCA W | Director | SELL | $252.00 | 207 | $52,164 | 11,862 | -1.7% |
| 2021-08-18 19:29 | 2021-08-18 | Fraser Claire | Director | SELL | $251.58 | 387 | $97,361 | 20,220 | -1.9% |
| 2021-08-18 19:23 | 2021-08-17 | RIMEL REBECCA W | Director | SELL | $252.00 | 207 | $52,164 | 12,069 | -1.7% |
| 2021-08-09 20:23 | 2021-08-06 | Spoerel Thomas J | Officer - VP Controller & Chief Acct Off | SELL | $242.30 | 266 | $64,452 | 1,285 | -17.2% |
| 2021-06-02 15:50 | 2021-05-28 | Lim James C | Officer - Executive Vice President | SELL | $241.68 | 3,429 | $828,721 | 801 | -81.1% |
| 2021-05-28 16:57 | 2021-05-27 | Fraser Claire | Director | SELL | $241.36 | 390 | $94,130 | 20,607 | -1.9% |
| 2020-11-25 00:52 | 2020-11-23 | Goette Roland | Officer - EVP and President, EMEA | OPT+S | $230.10 | 930 | $213,993 | 7,994 | 0.0% |
| 2020-07-13 16:31 | 2020-07-09 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | SELL | $260.00 | 1,272 | $330,720 | 10,340 | -11.0% |
| 2020-06-05 22:07 | 2020-06-05 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | SELL | $243.20 | 1,049 | $255,117 | 11,612 | -8.3% |
| 2020-06-02 21:24 | 2020-06-02 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | SELL | $244.83 | 222 | $54,352 | 14,688 | -1.5% |
| 2020-05-08 21:29 | 2020-05-08 | Fraser Claire | Director | SELL | $256.56 | 771 | $197,808 | 20,168 | -3.7% |
| 2020-03-17 20:03 | 2020-03-16 | Khichi Samrat S. | Officer - EVP and General Counsel | SELL | $224.53 | 4,349 | $976,481 | 5,262 | -45.3% |
| 2020-02-11 23:17 | 2020-02-11 | Fraser Claire | Director | SELL | $258.72 | 1,500 | $388,074 | 20,939 | -6.7% |
| 2020-02-05 22:48 | 2020-02-04 | Campion Simon D | Officer - EVP and Segment President | OPT+S | $285.09 | 8,085 | $2,304,953 | 10,773 | 0.0% |
| 2020-02-05 17:13 | 2020-02-04 | Mas Ribo Alberto | Officer - EVP and Pres, Life Sciences | SELL | $285.00 | 1,430 | $407,550 | 8,381 | -14.6% |
| 2020-01-29 01:05 | 2020-01-28 | FORLENZA VINCENT A | Director, Officer - Chairman, CEO and President | OPT+S | $280.96 | 28,514 | $8,011,293 | 208,864 | 0.0% |
| 2020-01-28 00:42 | 2020-01-23 | FORLENZA VINCENT A | Director, Officer - Chairman, CEO and President | OPT+S | $280.09 | 39,007 | $10,925,568 | 208,864 | 0.0% |
| 2020-01-10 22:01 | 2020-01-08 | FORLENZA VINCENT A | Director, Officer - Chairman, CEO and President | OPT+S | $275.17 | 33,535 | $9,227,709 | 208,864 | 0.0% |
| 2020-01-03 17:08 | 2020-01-02 | FORLENZA VINCENT A | Director, Officer - Chairman, CEO and President | OPT+S | $271.28 | 33,365 | $9,051,257 | 208,864 | 0.0% |
| 2019-12-18 17:45 | 2019-12-16 | Mas Ribo Alberto | Officer - EVP and Pres, Life Sciences | OPT+S | $269.51 | 11,860 | $3,196,389 | 9,811 | 0.0% |
| 2019-12-17 19:39 | 2019-12-16 | Polen Thomas E Jr | Officer - Executive Vice President | OPT+S | $269.63 | 6,386 | $1,721,857 | 17,117 | 0.0% |
| 2019-12-16 17:17 | 2019-12-12 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | OPT+S | $263.23 | 339 | $89,235 | 15,310 | 0.0% |
| 2019-12-16 17:15 | 2019-12-12 | FORLENZA VINCENT A | Director, Officer - Chairman, CEO and President | OPT+S | $265.57 | 11,626 | $3,087,517 | 209,050 | 0.0% |
| 2019-12-16 17:10 | 2019-12-13 | Spoerel Thomas J | Officer - VP Controller & Chief Acct Off | SELL | $267.95 | 506 | $135,583 | 1,035 | -32.8% |
| 2019-12-07 00:11 | 2019-12-06 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | SELL | $261.51 | 312 | $81,591 | 15,310 | -2.0% |
| 2019-09-10 17:50 | 2019-09-06 | FORLENZA VINCENT A | Director, Officer - Chairman, CEO and President | OPT+S | $260.38 | 11,532 | $3,002,702 | 221,088 | 0.0% |
| 2019-09-09 20:50 | 2019-09-06 | Polen Thomas E Jr | Officer - Executive Vice President | OPT+S | $260.26 | 5,823 | $1,515,494 | 16,455 | 0.0% |
| 2019-09-09 20:19 | 2019-09-06 | Bodner Charles R | Officer - SVP Corp Fin Chief Acct Office | OPT+S | $260.08 | 1,514 | $393,761 | 2,037 | 0.0% |
| 2019-09-09 17:55 | 2019-09-06 | Lim James C | Officer - Executive Vice President | OPT+S | $263.53 | 9,299 | $2,450,565 | 17,193 | 0.0% |
| 2019-09-03 16:47 | 2019-08-30 | Conroy Alexandre | Officer - EVP of Integrated Supply Chain | SELL | $256.72 | 46 | $11,809 | 16,489 | -0.3% |
| 2019-08-29 23:39 | 2019-08-29 | Conroy Alexandre | Officer - EVP of Integrated Supply Chain | SELL | $255.06 | 9,829 | $2,506,985 | 16,535 | -37.3% |
| 2019-08-12 18:21 | 2019-08-09 | Lim James C | Officer - Executive Vice President | OPT+S | $253.31 | 23,879 | $6,048,789 | 17,193 | 0.0% |
| 2019-08-12 16:57 | 2019-08-09 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | SELL | $253.78 | 127 | $32,230 | 15,930 | -0.8% |
| 2019-08-09 18:11 | 2019-08-08 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | OPT+S | $246.55 | 400 | $98,620 | 16,057 | 0.0% |
| 2019-08-09 17:49 | 2019-08-08 | Goette Roland | Officer - EVP and President, EMEA | OPT+S | $249.88 | 1,717 | $429,044 | 6,247 | 0.0% |
| 2019-08-09 17:09 | 2019-08-08 | Lim James C | Officer - Executive Vice President | OPT+S | $252.01 | 1,929 | $486,127 | 17,193 | 0.0% |
| 2019-08-07 21:56 | 2019-08-07 | Fraser Claire | Director | SELL | $243.26 | 1,429 | $347,619 | 21,544 | -6.2% |
| 2019-06-13 20:57 | 2019-06-12 | Campion Simon D | Officer - EVP and Segment President | SELL | $236.94 | 2,903 | $687,837 | 9,408 | -23.6% |
| 2019-06-11 16:24 | 2019-06-10 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | OPT+S | $241.03 | 191 | $46,037 | 16,207 | 0.0% |
| 2019-06-05 20:25 | 2019-06-04 | Kaltenbach Patrick | Officer - EVP & Pres Life Sciences | SELL | $235.00 | 275 | $64,625 | 16,207 | -1.7% |
| 2019-05-30 20:12 | 2019-04-17 | BURZIK CATHERINE M | Director | SELL | $223.04 | 45 | $10,037 | 10,007 | -0.4% |
How to Interpret $BDX Trades
Not every insider transaction in BECTON DICKINSON & CO is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BDX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for BDX
Insider activity data for BECTON DICKINSON & CO is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BDX, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.